Skip to content
Riskpilot
← Back to search
Sign in
Get full access
B&K Medical AB
AB
Active
Org 5593878118
Sveavägen 30 B, 191 34
Sollentuna
Medical specialists activities
· NACE 8622
Est. 2022
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
B&K Medical AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
3M
2M
2023
3M
2024
2M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
1M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
1 983
2 710
2 307
Staff expenses
−649
−1 068
−1 091
EBITDA
1 331
1 624
1 184
Depreciation & amort.
—
—
—
EBIT
1 331
1 624
1 184
Net financials
—
15
1
Profit before tax
1 331
1 239
885
Tax
−274
−254
−186
Net profit
1 057
985
699
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
1 841
3 534
3 690
Equity
1 057
1 577
1 975
Long-term debt
—
0
0
Short-term debt
784
1 257
715
Total debt
784
1 257
715
Financial ratios
5-year trend
EBITDA margin
51.3%
This company
15.8%
Market median
+225% vs market
2023
2025
Equity ratio
53.5%
This company
38.2%
Market median
+40% vs market
2023
2025
Return on equity
35.4%
This company
18.4%
Market median
+92% vs market
2023
2025
Net profit margin
30.3%
This company
8.1%
Market median
+274% vs market
2023
2025
Asset turnover
0.63×
This company
1.12×
Market median
-44% vs market
2023
2025
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-06-01 – 2025-05-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-06-01 – 2024-05-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-04 – 2023-05-31
View
PDF
More on B&K Medical AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network